Inger Løbersli
Norwegian Institute of Public Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Inger Løbersli.
Journal of Microbiological Methods | 2012
Inger Løbersli; Kjersti Haugum; Bjørn-Arne Lindstedt
Our laboratory has previously published two multiple-locus variable-number tandem-repeats analysis (MLVA) methods for rapid genotyping of Escherichia coli (E. coli), which are now in routine use for surveillance and outbreak detection. The first assay developed was specific for E. coli O157:H7; however this assay was not suitable for genotyping other E. coli serotypes. A new generic MLVA-assay was then developed with the capability of genotyping all E. coli serotypes. This generic E. coli MLVA (GECM7) was based on polymorphism in seven variable number of tandem repeats (VNTR) loci. GECM7 worked well with the majority of E. coli serotypes; however we wanted to increase the resolution for this method based in part of comparison with PFGE typing of E. coli O26:H11, where PFGE appeared to display higher resolution. The GECM7 method was improved by adding three new repeat-loci to a total of ten (GECM10), and a considerable increase in resolution was observed (from 296 to 507 genotypes on the same set of strains).
Applied and Environmental Microbiology | 2012
Lin Thorstensen Brandal; Camilla Sekse; Bjørn Arne Lindstedt; Marianne Sunde; Inger Løbersli; Anne Margrete Urdahl; Georg Kapperud
ABSTRACT A previous national survey of Escherichia coli in Norwegian sheep detected eae-positive (eae +) E. coli O26:H11 isolates in 16.3% (80/491) of the flocks. The purpose of the present study was to evaluate the human-pathogenic potential of these ovine isolates by comparing them with E. coli O26 isolates from humans infected in Norway. All human E. coli O26 isolates studied carried the eae gene and shared flagellar type H11. Two-thirds of the sheep flocks and 95.1% of the patients harbored isolates containing arcA allele type 2 and espK and were classified as enterohemorrhagic E. coli (EHEC) (stx positive) or EHEC-like (stx negative). These isolates were further divided into group A (EspK2 positive), associated with stx 2-EDL933 and stcE O103, and group B (EspK1 positive), associated with stx 1a. Although the stx genes were more frequently present in isolates from patients (46.3%) than in those from sheep flocks (5%), more than half of the ovine isolates in the EHEC/EHEC-like group had multiple-locus variable number of tandem repeat analysis (MLVA) profiles that were identical to those seen in stx-positive human O26:H11 isolates. This indicates that EHEC-like ovine isolates may be able to acquire stx-carrying bacteriophages and thereby have the possibility to cause serious illness in humans. The remaining one-third of the sheep flocks and two of the patients had isolates fulfilling the criteria for atypical enteropathogenic E. coli (aEPEC): arcA allele type 1 and espK negative (group C). The majority of these ovine isolates showed MLVA profiles not previously seen in E. coli O26:H11 isolates from humans. However, according to their virulence gene profile, the aEPEC ovine isolates should be considered potentially pathogenic for humans. In conclusion, sheep are an important reservoir of human-pathogenic E. coli O26:H11 isolates in Norway.
Journal of Clinical Microbiology | 2015
Lin Thorstensen Brandal; Hege Smith Tunsjø; Trond Egil Ranheim; Inger Løbersli; Heidi Lange; Astrid Louise Wester
E scherichia albertii is an emerging human enteric pathogen ([1][1]). It belongs to the attaching and effacing group of bacteria, which also includes enteropathogenic and Shiga toxin-producing Escherichia coli (EPEC and STEC, respectively). Shiga toxin-producing E. albertii has been described,
Journal of Applied Microbiology | 2011
Kjersti Haugum; Lin Thorstensen Brandal; Inger Løbersli; Georg Kapperud; Bjørn-Arne Lindstedt
Aims: To compare 167 Norwegian human and nonhuman Escherichia coli O157:H7/NM (nonmotile) isolates with respect to an A/T single nucleotide polymorphism (SNP) in the tir gene and to detect specific SNPs that differentiate STEC O157 into distinct virulence clades (1–3 and 8).
Journal of Clinical Microbiology | 2012
Lin Thorstensen Brandal; Inger Løbersli; T L Stavnes; Astrid Louise Wester; Bjørn-Arne Lindstedt
Sorbitol-fermenting Escherichia coli O157:H− (SF O157) is an emerging pathogen, and several outbreaks have been detected in Europe over the last few years ([12][1]). SF O157 is described as an aggressive pathogen frequently giving rise to hemolytic uremic syndrome (HUS) ([9][2]). The reservoir and
European journal of microbiology and immunology | 2016
Inger Løbersli; Astrid Lousie Wester; Åse Kristiansen; Lin Thorstensen Brandal
A real-time polymerase chain reaction (PCR) assay, amplifying the genes encoding lactose permease (lacY) and invasion plasmid antigen H (ipaH), was run on 121 isolates phenotypically classified as Shigella spp., enteroinvasive Escherichia coli (EIEC), or EIEC O nontypable (ONT). The results were compared with data from a generic E. coli multiple-locus variable-number of tandem repeat analysis (MLVA) and a Shigella MLVA. The real-time PCR verified all Shigella spp. (n = 53) as Shigella (lacY negative) and all EIEC O121 (n = 15) and EIEC O124 (n = 2) as EIEC (lacY positive). However, the real-time PCR typed EIEC O164 as either EIEC (n = 2) or Shigella (n = 2) and, thus, was not suited for classifying this group of isolates. Interestingly, the majority (42/47, 89.4%) of the EIEC ONT were classified as Shigella (lacY negative) by the real-time PCR, and in nearly all cases, (92.9%, 39/42) data from both MLVA assays supported these findings. Overall, in 94.7% (114/121) of the isolates, the results from the real-time PCR were substantiated by the results from the MLVA assays. In conclusion, the real-time PCR assay was fast and accurate in differentiating Shigella spp. from EIEC, with the exception of the EIEC O164 group. This molecular assay was particularly pragmatic for the challenging EIEC ONT group.
Fems Microbiology Letters | 2010
Angelika Miko; Bjørn-Arne Lindstedt; Lin Thorstensen Brandal; Inger Løbersli; Lothar Beutin
BMC Infectious Diseases | 2015
Lin Thorstensen Brandal; Astrid Lousie Wester; Heidi Lange; Inger Løbersli; Bjørn-Arne Lindstedt; Line Vold; Georg Kapperud
Fems Microbiology Letters | 2012
Kjersti Haugum; Bjørn-Arne Lindstedt; Inger Løbersli; Georg Kapperud; Lin Thorstensen Brandal
Microbial Pathogenesis | 2016
Kristoffer K. Olavesen; Bjørn-Arne Lindstedt; Inger Løbersli; Lin Thorstensen Brandal